HKD 13.76
(-1.57%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 0.90 CNY | -22.41% |
2022 | 1.16 CNY | -17.14% |
2021 | 1.40 CNY | 41.41% |
2020 | 0.99 CNY | 80.0% |
2019 | 0.55 CNY | 44.74% |
2018 | 0.38 CNY | 46.15% |
2017 | 0.26 CNY | 13.04% |
2016 | 0.23 CNY | -39.47% |
2015 | 0.38 CNY | 815.66% |
2014 | 0.04 CNY | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 0.54 CNY | 315.38% |
2024 Q1 | 0.13 CNY | -50.0% |
2024 Q3 | 0.19 CNY | -68.52% |
2023 Q1 | 0.30 CNY | -14.29% |
2023 FY | - CNY | -22.41% |
2023 Q4 | 0.26 CNY | 30.0% |
2023 Q3 | 0.20 CNY | -45.95% |
2023 Q2 | 0.37 CNY | 23.33% |
2022 Q1 | 0.21 CNY | -73.08% |
2022 FY | - CNY | -17.14% |
2022 Q4 | 0.35 CNY | -25.53% |
2022 Q3 | 0.47 CNY | 9.3% |
2022 Q2 | 0.43 CNY | 104.76% |
2021 FY | - CNY | 41.41% |
2021 Q4 | 0.78 CNY | 30.0% |
2021 Q3 | 0.60 CNY | 50.0% |
2021 Q1 | 0.21 CNY | -57.14% |
2021 Q2 | 0.40 CNY | 90.48% |
2020 Q2 | 0.48 CNY | 460.09% |
2020 Q1 | 0.09 CNY | -74.03% |
2020 Q3 | 0.26 CNY | -45.83% |
2020 FY | - CNY | 80.0% |
2020 Q4 | 0.49 CNY | 88.46% |
2019 Q1 | 0.06 CNY | -68.33% |
2019 FY | - CNY | 44.74% |
2019 Q4 | 0.33 CNY | 94.12% |
2019 Q3 | 0.17 CNY | 0.0% |
2019 Q2 | 0.17 CNY | 198.25% |
2018 Q1 | 0.05 CNY | -64.54% |
2018 FY | - CNY | 46.15% |
2018 Q4 | 0.18 CNY | 50.0% |
2018 Q3 | 0.12 CNY | -14.29% |
2018 Q2 | 0.14 CNY | 203.69% |
2017 Q4 | 0.13 CNY | 0.0% |
2017 FY | - CNY | 13.04% |
2016 FY | - CNY | -39.47% |
2015 FY | - CNY | 815.66% |
2014 FY | - CNY | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Uni-Bio Science Group Limited | 0.01 HKD | -8008.108% |
CK Life Sciences Int'l., (Holdings) Inc. | 0.00 HKD | -49900.0% |